Zepbound boosts psoriasis clearance when added to Taltz: Topline data
Combination ixekizumab plus tirzepatide outperformed ixekizumab monotherapy for the treatment of both psoriasis and overweight or obesity, according to topline […]
Combination ixekizumab plus tirzepatide outperformed ixekizumab monotherapy for the treatment of both psoriasis and overweight or obesity, according to topline […]
Prevention in Lupus and Therapeutic Evolution in Sjögren’s explores the proactive approach in autoimmune diseases, mo https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu, 02/19/2026
https://academic.oup.com/rheumatology/article-pdf/60/10/4778/40500312/keab099.pdf (2021). Østergaard, M. & Lambert, R. G. W. Imaging in ankylosing …
The clinic began seeing patients Feb. 16 and offers consultations in neurology, neurosurgery and rheumatology, as well as laboratory services, …
Publication date: Available online 18 February 2026 Source: The Lancet Rheumatology Author(s): Shaozhe Cai, Ziwei Hu, Yu Chen, Cong Ye,
Publication date: Available online 18 February 2026 Source: The Lancet Rheumatology Author(s): Paul Dalmas, Lionel Galicier, Mikael Ebbo, Nicolas Schleinitz
… Rheumatology. The study was led by Susan Manzi of the Lupus Center of … Rheumatology. https://doi.org/10.1002/art.70041. Arthritis …
A Modern Approach to Osteoporosis Management am.castro222@g… Thu, 02/19/2026 – 08:00
Doctoral student. Esin Beste Yilmaz, Karolinska Institutet, Department of Medicine, Solna (MedS), Division of Rheumatology.
In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights the latest issue’s cover
As osteoporosis care evolves, so too do the questions surrounding how best to deploy the therapies already available. At the
Objective Dysregulated type I interferon (IFN) signaling contributes to autoimmune myositis pathogenesis. We investigated the therapeutic effects of JAK inhibitors
Objective Our study’s objective is to investigate the specific role of tryptophan metabolism, especially that of microbiome-derived metabolites, in the
Objective Complement component 4 (C4), encoded by C4A and C4B within the major histocompatibility complex (MHC) on chromosome 6, regulates
Mod Rheumatol. 2026 Feb 19:roag011. doi: 10.1093/mr/roag011. Online ahead of print. ABSTRACT OBJECTIVE: To evaluate the long-term safety and exploratory
J Crohns Colitis. 2026 Feb 1;20(Supplement_2):ii1-ii2. doi: 10.1093/ecco-jcc/jjaf168. NO ABSTRACT PMID:41711040 | DOI:10.1093/ecco-jcc/jjaf168
Front Immunol. 2026 Feb 3;17:1716099. doi: 10.3389/fimmu.2026.1716099. eCollection 2026. ABSTRACT BACKGROUND: Interleukin (IL)-38 has been recently identified as an anti-inflammatory
Front Immunol. 2026 Feb 3;17:1734274. doi: 10.3389/fimmu.2026.1734274. eCollection 2026. ABSTRACT BACKGROUND: Although the existence of antiphospholipid antibodies (aPL) has been
In Vitro Model. 2025 Nov 13;4(3-4):245-259. doi: 10.1007/s44164-025-00097-4. eCollection 2025 Oct. ABSTRACT PURPOSE: Isolation of primary human hepatocytes (PHH) from
J Multidiscip Healthc. 2026 Feb 11;19:578454. doi: 10.2147/JMDH.S578454. eCollection 2026. ABSTRACT BACKGROUND: Rheumatoid arthritis (RA) significantly impairs patients’ quality of
Case Rep Pediatr. 2026 Feb 17;2026:5552173. doi: 10.1155/crpe/5552173. eCollection 2026. ABSTRACT Primary lung neoplasms in children are uncommon, with a
Open Access Rheumatol. 2026 Feb 11;18:571893. doi: 10.2147/OARRR.S571893. eCollection 2026. ABSTRACT BACKGROUND/PURPOSE: The advent of targeted therapies, such as biologic
Clin Kidney J. 2026 Jan 15;19(2):sfag012. doi: 10.1093/ckj/sfag012. eCollection 2026 Feb. ABSTRACT BACKGROUND: Kidney transplantation (KT) is the preferred treatment
Rheumatol Adv Pract. 2026 Feb 4;10(1):rkag020. doi: 10.1093/rap/rkag020. eCollection 2026. ABSTRACT OBJECTIVES: To develop and validate a clinical prediction rule
Rheumatol Adv Pract. 2026 Jan 25;10(1):rkag009. doi: 10.1093/rap/rkag009. eCollection 2026. ABSTRACT OBJECTIVES: To assess the 2-year impact of bimekizumab on
Front Pediatr. 2026 Feb 3;14:1702667. doi: 10.3389/fped.2026.1702667. eCollection 2026. ABSTRACT OBJECTIVE: This study aims to compare the frequency of instances
Yonago Acta Med. 2026 Jan 24;69(1):78-87. doi: 10.33160/yam.2026.02.009. eCollection 2026 Feb. ABSTRACT BACKGROUND: Performance status is a useful prognostic index